13F
中

TELO TELOMIR PHARMACEUTICALS INC

2026Q1 · CUSIP 87975F104 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
26
Δ holders QoQ
-7
Breadth percentile
n/a
Whale holders
12
Δ whales
-1
Inst. holding value
$3M
New positions
5
Closed positions
12
Price momentum (1Q)
—
Put / Call
0/0

Breadth history (34 quarters)

2024Q2: Δ+18 · h=26 2024Q3: Δ+9 · h=35 2024Q4: Δ+5 · h=40 2025Q1: Δ+3 · h=43 2025Q2: Δ+1 · h=44 2025Q3: Δ-12 · h=32 2025Q4: Δ+1 · h=33 2026Q1: Δ-7 · h=26 2024Q2: holders=26 2024Q3: holders=35 2024Q4: holders=40 2025Q1: holders=43 2025Q2: holders=44 2025Q3: holders=32 2025Q4: holders=33 2026Q1: holders=26 -18 -9 +0 +9 +18 233547 24Q224Q324Q425Q125Q225Q325Q426Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 0 lit events

No lit events in history

Options Sentiment

Put holders
0
QoQ: 0
Call holders
0
QoQ: 0

See methodology →

Fundamentals

PE (TTM)
—
EPS (TTM)
$-0.29
EPS YoY
—
Revenue (TTM)
—
Revenue YoY
—
Quarterly Revenue & EPS (4Y)
2023-03-31: EPS -0.02 2023-06-30: EPS -0.06 2023-09-30: EPS -0.06 2023-12-31: EPS 0.62 2024-03-31: EPS -0.23 2024-06-30: EPS 0.05 2024-09-30: EPS -0.20 2024-12-31: EPS -0.18 2025-03-31: EPS -0.07 2025-06-30: EPS 0.17 2025-09-30: EPS -0.03 2025-12-31: EPS -0.40 2026-03-31: EPS -0.03 -0.44 0.12 0.68 2023202420252026 EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 19 2023-12-31: PE 18.82024-03-31: PE 22.92024-06-30: PE 10.52024-09-30: PE 15.5 9 17 24 2023202420252026

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)